Riskpilot← Back to searchSign inGet full accessNORDHAVN 3.09 ApS
APSActiveCVR 44448033Nymøllevej 6Buying and selling of own real estate · NACE 6811Est. 2023— employees
Revenue 2025
DKK -25K
+3% vs 2024
EBITDA margin
100.0%
-3% vs 2024
Equity ratio
-6.2%
Financial strength
Net profit 2025
DKK -80K
-119% vs 2024
| Revenue | DKK -25K | +3% |
| EBITDA | DKK -25K | -3% |
| Net profit | DKK -80K | -119% |
| Total assets | DKK 1,3M | +11% |
| Equity | DKK -77K | -2496% |
| Employees | — | — |
Legal name
NORDHAVN 3.09 ApS
CVR number
44448033
Legal form
Anpartsselskab
NACE code
6811 · Buying and selling of own real estate
Founded
13. november 2023
Share capital
DKK 40.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør i forening med bestyrelsesformanden eller af 3
bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er at erhverve og udvikle en projektejendom beliggende på byggefelt
3.09 i Nordhavn, endnu ikke udstykket del af matr.nr. 3a Frihavnskvarteret.
Address
Nymøllevej 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | -24 | -25 |
| Staff expenses | -0 | -0 |
| EBITDA | -24 | -25 |
| Depreciation & amort. | -0 | -0 |
| EBIT | -24 | -25 |
| Net financials | -13 | -56 |
| Profit before tax | -37 | -80 |
| Tax | -0 | -0 |
| Net profit | -37 | -80 |
| Item | 2024 | 2025 |
|---|---|---|
| Total assets | 1.124 | 1.253 |
| Equity | 3 | -77 |
| Long-term debt | 0 | 0 |
| Short-term debt | 1.121 | 1.330 |
| Total debt | 1.121 | 1.330 |
EBITDA margin
-2470200.0%
This company
15.8%
Market median
-15634277% vs market
20242025
Equity ratio
-6.2%
This company
38.2%
Market median
-116% vs market
20242025
Return on equity
-8039500.0%
This company
18.4%
Market median
-43693035% vs market
20242025
Net profit margin
-8039500.0%
This company
8.1%
Market median
-99253186% vs market
20242025
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
20242025
Debt / equity
17.23×
This company
0.62×
Market median
-2679% vs market
20242025
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DI Management | Management | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
TL | Board of Directors | 2023 |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2023 | |
| Company | 50–66.65% | 50–66.65% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
T&W Medical A/S
NORDHAVN 3.09 ApS Board members of NORDHAVN 3.09 ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dan Ingemann Petersen | Management | 0 companies |
| Mads Nørby Hansen | Board of Directors | 0 companies |
| Casper Moltke-Leth | Chairman | 0 companies |
| Tom Lotz | Board of Directors | 0 companies |